Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalReturn on AssetsReturn on EquityReturn on Sales

Trinity Biotech (TRIB) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Trinity Biotech (TRIB) over the last 12 years, with Q2 2025 value amounting to 0.5.

  • Trinity Biotech's Equity Ratio fell 5957.38% to 0.5 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.5, marking a year-over-year decrease of 5957.38%. This contributed to the annual value of 0.34 for FY2024, which is 1547.12% up from last year.
  • Latest data reveals that Trinity Biotech reported Equity Ratio of 0.5 as of Q2 2025, which was down 5957.38% from 0.34 recorded in Q4 2024.
  • Trinity Biotech's Equity Ratio's 5-year high stood at 0.15 during Q2 2022, with a 5-year trough of 0.5 in Q2 2025.
  • For the 5-year period, Trinity Biotech's Equity Ratio averaged around 0.14, with its median value being 0.07 (2023).
  • Examining YoY changes over the last 5 years, Trinity Biotech's Equity Ratio showed a top increase of 381271.56% in 2022 and a maximum decrease of 624264.35% in 2022.
  • Quarter analysis of 5 years shows Trinity Biotech's Equity Ratio stood at 0.0 in 2021, then crashed by 780.55% to 0.02 in 2022, then tumbled by 1605.55% to 0.4 in 2023, then increased by 15.47% to 0.34 in 2024, then crashed by 45.98% to 0.5 in 2025.
  • Its Equity Ratio stands at 0.5 for Q2 2025, versus 0.34 for Q4 2024 and 0.27 for Q3 2024.